Saturday, December 4, 2021

I-Spy COVID Trial for Critically Ill Terminated: No Large Impact

Today, Quantum Leap Healthcare Collaborative (QLHC), sponsor of the I-SPY COVID Trial, announced that the IC14 arm of the trial has been terminated. This decision was due to the high probability that IC14 would not have a large impact on either shortening time to recovery or mortality in critically ill patients with COVID-19. - eTurboNews | Trends | Travel News

No comments:

Post a Comment